These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17711903)

  • 1. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.
    Biggioggero M; Borghi MO; Gerosa M; Trespidi L; Cimaz R; Meroni PI
    Lupus; 2007; 16(8):651-6. PubMed ID: 17711903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy.
    Cimaz R; Meregalli E; Biggioggero M; Borghi O; Tincani A; Motta M; Airò P; Meroni PL
    Toxicol Lett; 2004 Apr; 149(1-3):155-62. PubMed ID: 15093261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents.
    Motta M; Ciardelli L; Marconi M; Tincani A; Gasparoni A; Lojacono A; Chirico G
    Am J Perinatol; 2007 Sep; 24(8):441-7. PubMed ID: 17992710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonates born from mothers with autoimmune disorders.
    Motta M; Rodriguez-Perez C; Tincani A; Lojacono A; Nacinovich R; Chirico G
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S67-70. PubMed ID: 19765919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of children exposed antenatally to immunosuppressive drugs.
    Motta M; Tincani A; Meroni PL; Cimaz R
    Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii32-4. PubMed ID: 18504283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome.
    Tincani A; Rebaioli CB; Frassi M; Taglietti M; Gorla R; Cavazzana I; Faden D; Taddei F; Lojacono A; Motta M; Trepidi L; Meroni P; Cimaz R; Ghirardello A; Doria A; Pisoni MP; Muscarà M; Brucato A;
    Autoimmun Rev; 2005 Sep; 4(7):423-8. PubMed ID: 16137607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders.
    Cimaz R; Meregalli E; Biggioggero M; Airò P; Danieli E; Antonioli CM; Motta M; Chirico G; Columbrita D; Frassi M; Meroni PL; Tincani A
    Lupus; 2007; 16(2):129-32. PubMed ID: 17402369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants.
    Meregalli E; Biggioggero M; Borghi O; Meroni P; Cimaz R
    Arh Hig Rada Toksikol; 2005 Jun; 56(2):151-6. PubMed ID: 15968830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated lupus erythematosus and pregnancy].
    Derksen RH; Out HJ; Christiaens GC
    Ned Tijdschr Geneeskd; 1989 May; 133(20):1025-9. PubMed ID: 2739776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Exposure in utero to immunosuppressives].
    Prévot A; Martini S; Guignard JP
    Rev Med Suisse Romande; 2001 Apr; 121(4):283-91. PubMed ID: 11400400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases in pregnancy: their effect on the fetus and newborn.
    Giacoia GP; Azubuike K
    Obstet Gynecol Surv; 1991 Nov; 46(11):723-32. PubMed ID: 1745470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents.
    Takahashi N; Nishida H; Hoshi J
    Transplantation; 1994 Jun; 57(11):1617-21. PubMed ID: 8009597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theoretical basis of immunosuppression in autoimmune diseases].
    Haustein UF
    Dermatol Monatsschr; 1972 Aug; 158(8):547-71. PubMed ID: 4404036
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs in autoimmune diseases.
    Herrmann DB; Bicker U
    Klin Wochenschr; 1990; 68 Suppl 21():15-25. PubMed ID: 2198387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why so many women? Part 1. Systemic lupus erythematosus.
    Lash AA
    Medsurg Nurs; 1993 Aug; 2(4):259-64. PubMed ID: 8348181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
    Ferraccioli GF; Tomietto P; De Santis M
    Ann N Y Acad Sci; 2005 Jun; 1051():658-65. PubMed ID: 16127006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
    Reddy D; Murphy SJ; Kane SV; Present DH; Kornbluth AA
    Am J Gastroenterol; 2008 May; 103(5):1203-9. PubMed ID: 18422816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy in autoimmune diseases.
    Gabbe SG
    Clin Obstet Gynecol; 1983 Sep; 26(3):635-41. PubMed ID: 6352127
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulation in autoimmune diseases.
    Gergely P; Láng I; Gonzalez-Cabello R; Fehér J
    Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.